This inventor holds 1 USPTO granted patent. Top assignee: Natco Pharma Limited. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Naresh Ghanta: Innovator in Pharmaceutical Chemistry
Introduction
Naresh Ghanta is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. His work is characterized by a focus on improving processes for drug preparation.
Latest Patents
Naresh Ghanta holds a patent for the "Process for the preparation of ribociclib succinate and its novel crystalline forms thereof." This invention relates to an improved method for synthesizing the compound 7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide succinate (1/1), represented by the structural formula known as Formula-1a. This innovative process enhances the efficiency and effectiveness of drug formulation.
Career Highlights
Naresh Ghanta is associated with Natco Pharma Limited, a leading pharmaceutical company known for its commitment to research and development. His role at Natco Pharma has allowed him to contribute to various projects aimed at advancing pharmaceutical technologies.
Collaborations
Throughout his career, Naresh has collaborated with talented professionals, including Arunkumar Thiriveedhi and Swapna Kondaveeti. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Naresh Ghanta's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the preparation of ribociclib succinate, highlight the importance of research in developing effective medications. His ongoing efforts continue to impact the field positively.